Edward Cochran

742 total citations
9 papers, 258 citations indexed

About

Edward Cochran is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pharmacology. According to data from OpenAlex, Edward Cochran has authored 9 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Edward Cochran's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Edward Cochran is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Edward Cochran collaborates with scholars based in United States and Netherlands. Edward Cochran's co-authors include Takashi Kishimoto, B. W. Rice, Stephen Lee, Jae‐Beom Kim, Kenneth D. Campbell, Lu Zhan, Peter Lassota, He Zhou, Jamey Guess and Svetlana Patrikeeva and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Edward Cochran

9 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward Cochran United States	6	102	46	43	43	37	9	258
Yingdai Gao China	13	301 3.0×	31 0.7×	30 0.7×	16 0.4×	86 2.3×	42	536
Åsmund Flobak Norway	10	221 2.2×	9 0.2×	17 0.4×	79 1.8×	57 1.5×	24	376
Nataly Tarasenko Israel	13	258 2.5×	35 0.8×	14 0.3×	20 0.5×	81 2.2×	22	376
Amber Jean Tietgens United States	10	316 3.1×	31 0.7×	7 0.2×	19 0.4×	48 1.3×	12	591
Annegret Boge United States	7	376 3.7×	17 0.4×	9 0.2×	32 0.7×	65 1.8×	12	479
Élie Hadchity France	7	258 2.5×	29 0.6×	12 0.3×	14 0.3×	48 1.3×	9	342
Anja Bastian United States	12	188 1.8×	114 2.5×	10 0.2×	30 0.7×	97 2.6×	14	357
Masakazu Inazuka Japan	8	223 2.2×	37 0.8×	7 0.2×	51 1.2×	61 1.6×	13	331
Sandrine Ferrand Switzerland	8	163 1.6×	18 0.4×	15 0.3×	13 0.3×	39 1.1×	10	248

Countries citing papers authored by Edward Cochran

Since Specialization

Citations

This map shows the geographic impact of Edward Cochran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Cochran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Cochran more than expected).

Fields of papers citing papers by Edward Cochran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Cochran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Cochran. The network helps show where Edward Cochran may publish in the future.

Co-authorship network of co-authors of Edward Cochran

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Cochran. A scholar is included among the top collaborators of Edward Cochran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Cochran. Edward Cochran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Roy, Sucharita, Tatiana Nanovskaya, Svetlana Patrikeeva, et al.. (2019). M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model. American Journal of Obstetrics and Gynecology. 220(5). 498.e1–498.e9. 43 indexed citations

Choudhury, Amit, Daniel Ortiz, Kevin Garofalo, et al.. (2019). Abstract 561: Discovery of a potential best-in-class anti-CD38 therapeutic utilizing Fc multimerization. Cancer Research. 79(13_Supplement). 561–561. 1 indexed citations

Guess, Jamey, Chia Lin Chu, Edward Cochran, et al.. (2018). Necuparanib, A Multitargeting Heparan Sulfate Mimetic, Targets Tumor and Stromal Compartments in Pancreatic Cancer. Molecular Cancer Therapeutics. 18(2). 245–256. 18 indexed citations

Ling, Leona, Sucharita Roy, Tatiana Nanovskaya, et al.. (2018). 32: M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex-vivo placental perfusion model. American Journal of Obstetrics and Gynecology. 220(1). S26–S26. 3 indexed citations

Ling, Lei, S. Roy, James W. Meador, et al.. (2015). THU0057 Targeting the Neonatal FC Receptor (FCRN) to Mediate Autoantibody Clearance in IgG-Driven Autoimmune Disease. Annals of the Rheumatic Diseases. 74. 212–212. 1 indexed citations

Kim, Jae‐Beom, Edward Cochran, Stephen Lee, et al.. (2010). Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo. PLoS ONE. 5(2). e9364–e9364. 128 indexed citations

Cochran, Edward, James L. Ellis, David S. Garvey, et al.. (2007). Structure-Based Design, Synthesis, and Biological Evaluation of Indomethacin Derivatives as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors. Journal of Medicinal Chemistry. 50(25). 6367–6382. 45 indexed citations

Ellis, James L., Edward Cochran, Richard A. Earl, et al.. (2005). NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor. Inflammopharmacology. 12(5-6). 521–534. 10 indexed citations

Young, Delano V., Edward Cochran, Vijay Dhawan, et al.. (2005). A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methods. Biochemical Pharmacology. 70(9). 1343–1351. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact